Allvivo Vascular, Inc Company Profile

21:11 EDT 25th September 2018 | BioPortfolio

Allvivo Vascular, Inc. (AVI) is a company founded in December of 2003 as a spin-off entity of allvivo, Inc. (allvivo). AVI holds an exclusive worldwide license for allvivo, Inc.'s biomimetic surface technologies in the cardiovascular field of use. Given allvivo's broad technology platform and opportunities to develop the EGAP coating for other markets, the spin-off strategy has provided strategic focus and dedicated funding for introducing allvivo's technology to the coronary market.
allvivo, Inc. was formed in December of 1999 in Birmingham, AL to design tools for proteomics and cellomics research based on proprietary coating technologies developed originally at the University of Utah's Center for Biopolymers and Interfaces. In the spring of 2002, the company relocated to Southern California and shifted its strategic focus to address clinical applications, i.e. drug device combination products. allvivo and AVI share a 5,000 sq.ft. research and administrative facility in Lake Forest, CA.


20914 Bake Parkway, Suite112
Lake Forest
United States of America


Phone: (949) 716-6478
Fax: (949) 716-6498

News Articles [307 Associated News Articles listed on BioPortfolio]

From Vascular Medicine: Focus on vascular imaging and diagnostics

(SAGE) Vascular disease is a leading cause of morbidity and death worldwide. In order to combat the disease, specialists must have skills with imaging techniques. With this in mind, Vascular Medicine,...

Vascular Endothelial Growth Factor remains unchanged in cerebrospinal fluid of patients with Alzheimer’s disease and vascular dementia

Increasing evidence suggests that cerebral vascular dysfunction is associated with the early stages of Alzheimer’s disease (AD). Vascular endothelial growth factor (VEGF) is one of the key players i...

Access Vascular brings in $1.9mm

In what appears to be its second financing, Access Vascular Inc. raised $1.9mm from seven undisclosed investors. The company could raise another $2.1mm in the round. Earlier this year, Access Vascular...

Intact Vascular gets $20mm in Series C

Intact Vascular Inc. (devices for minimally invasive peripheral vascular procedures) raised $20mm in its Series C financing to New Enterprise Associates, HIG BioVentures, and Quaker Partners. The fund...

Intact Vascular completes enrollment in Tack Optimized Balloon Angioplasty III trial

Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, announced that its Tack Optimized Balloon Angioplasty III (TOBA III) clinical trial has

Medical News Today: These antibiotics may endanger vascular health

Researchers in Sweden and Denmark find new evidence that suggests that a type of antibiotic can increase the risk of a potentially fatal vascular disease.

Intact Vascular gets $20M boost

A two-tranche Series C financing round pulled in $20 million for Wayne, Pa.-based Intact Vascular, which makes the Tack endov -More- 

The Role of Interleukin 6 in Vascular Calcification of CKD

A better understanding of the contribution of vascular calcification to cardiovascular mortality in CKD could have important therapeutic implications. Nephrology Dialysis Transplantation

PubMed Articles [1184 Associated PubMed Articles listed on BioPortfolio]

Hypoxia Signaling in Vascular Homeostasis.

Hypoxia signaling in the vasculature controls vascular permeability, inflammation, vascular growth, and repair of vascular injury. In this review, we summarize recent insights in this burgeoning field...

Pediatric Vascular Surgical Practice Patterns.

Vascular surgeons infrequently care for pediatric patients. As such, variability in operative management and available hospital resources at free-standing children's hospitals may exist. The study aim...

The role of adventitia in hypoxic vascular remodeling.

As an important site for the production, storage and release of key regulators for vascular function, the vascular adventitia is thought to be a damage sensing tissue in the vascular wall under certai...

Recent trends in Publications of US and European Directors in Vascular Surgery.

We hypothesized that there may be significant differences between academic productivity of the vascular training programs in the United States (US) and Europe. In an effort to explore theory, we revie...

Early Treatment at a Referral Center Improves Outcomes for Patients with Acute Vascular Disease.

Patients with acute vascular disease frequently need specialized management that may require transfer to a vascular referral center. While transfer may be medically necessary, it can delay definitive ...

Clinical Trials [1895 Associated Clinical Trials listed on BioPortfolio]

Patient Comfort With Vascular Closure

The purpose of this research study is to collect information on the amount of discomfort patients experience with one of two different vascular blood vessel closure devices, the MynxM5 Vas...

Clinical Study of POSS-PCU Vascular Grafts for Vascular Access

This study evaluates the safety and performance of a new vascular graft made of POSS-PCU as a vascular access conduit for haemodialysis. 30 patients requiring access for dialysis will be e...

Perioperative Aspirin Response in Patients Undergoing Vascular Surgery

Reduced antiplatelet activity (low response (LR)/high on-treatment platelet reactivity (HPR)) of aspirin (ALR) or clopidogrel (CLR) is associated with an increased risk of thromboembolic e...

A Feasibility Study Evaluating the Use of SafeBreak Vascular in the Geriatric Trauma Population

SafeBreak Vascular is a medical device indicated for fluid flow control during the administration of IV fluids/medication to the patient's vascular system and to aid in the prevention of u...

Study to Evaluate Safety & Effectiveness of Vascular Sealant System

To evaluate a new vascular sealant compared to control for the control of suture line bleeding after vascular reconstructive surgery.

Companies [321 Associated Companies listed on BioPortfolio]

Allvivo Vascular, Inc

Allvivo Vascular, Inc. (AVI) is a company founded in December of 2003 as a spin-off entity of allvivo, Inc. (allvivo). AVI holds an exclusive worldwide license for allvivo, Inc.'s biomimetic surface t...

LeMaitre Vascular

LeMaitre Vascular is a leading global provider of innovative devices for the treatment of peripheral vascular disease. We develop, manufacture, and market disposable and implantable vascular devices t...

The Foundation for Accelerated Vascular Research

The Foundation for Accelerated Vascular Research is a non-profit medical organization dedicated to accelerating research into the cause, prevention and treatment of vascular disease. Founded in 19...

Society for Vascular Surgery

The Society for Vascular Surgery (SVS) is a not-for-profit professional medical society, composed primarily of vascular surgeons, that seeks to advance excellence and innovation in vascular health thr...

Vascular Nanotransfer Technologies

Privately held VNT, based in Auburndale, Mass., is developing Drug-Coated Balloons (DCB) that are designed to be a more precise delivery vehicle and be the standard treatment of c...

More Information about "Allvivo Vascular, Inc" on BioPortfolio

We have published hundreds of Allvivo Vascular, Inc news stories on BioPortfolio along with dozens of Allvivo Vascular, Inc Clinical Trials and PubMed Articles about Allvivo Vascular, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Allvivo Vascular, Inc Companies in our database. You can also find out about relevant Allvivo Vascular, Inc Drugs and Medications on this site too.

Quick Search


Relevant Topics

Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Corporate Database Quicklinks

Searches Linking to this Company Record